ST. LOUIS--(BUSINESS WIRE)--C2N Diagnostics, LLC (“C2N”), a specialty diagnostics company with a vision to bring Clarity Through Innovation®, today announced a $10 million USD investment from Samsung ...

Samsung Electronics’ medical device division showed off a selection of new artificial intelligence-based imaging tools yesterday at the Radiological Society of North America’s 2018 Annual Meeting in ...

Samsung is backing Alzheimer’s disease blood test developer C2N Diagnostics, with $10 million to help scale up its commercial work and R&D pipeline. The conglomerate’s investment—which collectively ...

Samsung has announced its intention to acquire Sonio, a French artificial intelligence company, as part of its strategy to enhance its medical diagnostic systems. The use of AI technology has grown ...

Samsung Life Science Fund made its first strategic investment of the year into C2N Diagnostics LLC, underscoring the rising potential of blood-based diagnostics in detecting and monitoring the risk of ...